Cancer patients received letters from the prestigious Manhattan hospital in December claiming the insurer would soon drop their coverage, but there is now a tentative agreement in place to provide coverage through April 14.

At TIAA's recent "Securing Retirement in America" event, experts discussed the Lifetime Income for Employees Act, legislation introduced in Congress in 2023, and other solutions to improve lifetime income for workers.

The FDA has authorized roughly two dozen AI products to help diagnose cancer from mammograms, which are being rolled out in different states. However, patients must pay an extra fee – often $40 – for the AI analysis.

It is important as an advisor to understand all these topics and what impacts they are having on your clients so that you can provide the best advice possible.

Investors see a range of threats on the horizon in 2024, although AI will unlock new investment opportunities, says a Natixis survey of 500 investors who manage retirement and institutional assets.

A group of 19 senators sent a letter to the U.S. Department of Health and Human Services to rethink its appeal of a recent court decision permitting the use of copay accumulator programs that help patients pay for their drugs.

The pharmaceutical giant has launched a telehealth-connected website to allow patients to directly order the weight loss drug, as well as insulin products and a migraine drug, direct from the company.

Michigan's top insurance regulator told health plans on Monday that they cannot deny coverage for clinically proven cancer treatments, after a deceased patient's insurer refused to pay for life-saving gene therapy treatment.